Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Alexandre

Showing results (271-280 of 294) with videos related to

Pageof 30
Sort By:
The Prostate|November 25, 2014
The beta-3 adrenoceptor agonist, mirabegron relaxes isolated prostate from human and rabbit: new therapeutic indication?Fabiano B Calmasini, Tuany Z Candido, Eduardo C Alexandre, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 1, 1997
Effects of cyclical etidronate therapy on bone loss in early postmenopausal women who are not undergoing hormonal replacement therapyJ M Pouilles, F Tremollieres, C Roux, et al.
American Journal of Physiology. Renal Physiology|May 3, 2018
Deletion or pharmacological blockade of TLR4 confers protection against cyclophosphamide-induced mouse cystitisMariana G de Oliveira, Fabiola Z Mónica, Fabiano B Calmasini, et al.
Neurourology and Urodynamics|October 30, 2016
Long-term treatment with the beta-3 adrenoceptor agonist, mirabegron ameliorates detrusor overactivity and restores cyclic adenosine monophosphate (cAMP) levels in obese miceFabiano B Calmasini, Mariana G de Oliveira, Eduardo C Alexandre, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|December 21, 2000
Processing of vitamin A and E in the human gastrointestinal tractP Borel, B Pasquier, M Armand, et al.
Rheumatology (Oxford, England)|January 27, 2006
Continuation of treatment with infliximab in ankylosing spondylitis: 2-yr open follow-upL Gossec, A Le Henanff, M Breban, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2014
Soluble guanylyl cyclase (sGC) degradation and impairment of nitric oxide-mediated responses in urethra from obese mice: reversal by the sGC activator BAY 60-2770Eduardo C Alexandre, Luiz O Leiria, Fábio H Silva, et al.
Pharmaceuticals (Basel, Switzerland)|March 28, 2026
Valorization of Olive Stones: Chemical Composition and BioactivityBruna Nunes, Naiara Fernández, Andreia Bento Silva, et al.
Cardiovascular Drugs and Therapy|January 7, 2009
Native LDL-cholesterol mediated monocyte adhesion molecule overexpression is blocked by simvastatinCarlos V Serrano, Antônio Eduardo Pesaro, James A de Lemos, et al.
European Journal of Pharmacology|June 19, 2016
Chronic treatment with resveratrol improves overactive bladder in obese mice via antioxidant activityEduardo C Alexandre, Fabiano B Calmasini, Mariana G de Oliveira, et al.
Pageof 30

Showing results (271-280 of 294) with videos related to

Sort By:
Pageof 30
The Prostate|November 25, 2014
The beta-3 adrenoceptor agonist, mirabegron relaxes isolated prostate from human and rabbit: new therapeutic indication?Fabiano B Calmasini, Tuany Z Candido, Eduardo C Alexandre, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 1, 1997
Effects of cyclical etidronate therapy on bone loss in early postmenopausal women who are not undergoing hormonal replacement therapyJ M Pouilles, F Tremollieres, C Roux, et al.
American Journal of Physiology. Renal Physiology|May 3, 2018
Deletion or pharmacological blockade of TLR4 confers protection against cyclophosphamide-induced mouse cystitisMariana G de Oliveira, Fabiola Z Mónica, Fabiano B Calmasini, et al.
Neurourology and Urodynamics|October 30, 2016
Long-term treatment with the beta-3 adrenoceptor agonist, mirabegron ameliorates detrusor overactivity and restores cyclic adenosine monophosphate (cAMP) levels in obese miceFabiano B Calmasini, Mariana G de Oliveira, Eduardo C Alexandre, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|December 21, 2000
Processing of vitamin A and E in the human gastrointestinal tractP Borel, B Pasquier, M Armand, et al.
Rheumatology (Oxford, England)|January 27, 2006
Continuation of treatment with infliximab in ankylosing spondylitis: 2-yr open follow-upL Gossec, A Le Henanff, M Breban, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 15, 2014
Soluble guanylyl cyclase (sGC) degradation and impairment of nitric oxide-mediated responses in urethra from obese mice: reversal by the sGC activator BAY 60-2770Eduardo C Alexandre, Luiz O Leiria, Fábio H Silva, et al.
Pharmaceuticals (Basel, Switzerland)|March 28, 2026
Valorization of Olive Stones: Chemical Composition and BioactivityBruna Nunes, Naiara Fernández, Andreia Bento Silva, et al.
Cardiovascular Drugs and Therapy|January 7, 2009
Native LDL-cholesterol mediated monocyte adhesion molecule overexpression is blocked by simvastatinCarlos V Serrano, Antônio Eduardo Pesaro, James A de Lemos, et al.
European Journal of Pharmacology|June 19, 2016
Chronic treatment with resveratrol improves overactive bladder in obese mice via antioxidant activityEduardo C Alexandre, Fabiano B Calmasini, Mariana G de Oliveira, et al.
Pageof 30